India and Russia cooperate closely in the fight against Covid-19, including in vaccine trials and production, supply of critical medical supplies and repatriation of each other’s citizens. SPUTNIK-V received DCGI approval for emergency use in India on April 13, 2021, making it the first foreign-made vaccine to be permitted for use in India, and third overall.
Many leading Indian pharmaceutical companies continue discussion on the possible vaccine contenders including EpivacCorona being developed by Vector Institute, Chumakov vaccine, as well as the second vaccine being developed by Gamaleya Institute ‘Sputnik Light’. During the peak of COVID, India ensured supplies of the Hydroxychloroquine (HCQS) drug from IPCA labs to Russia.
Large quantities of other drugs like paracetamol and other antibiotics were also sustained during the first wave of pandemic in Russia.
What we do